PHI with Ulcerative (chronic) rectosigmoiditis
How does this condition affect your private health insurance?
Ulcerative rectosigmoiditis is a chronic inflammatory bowel disease (IBD) specifically affecting the rectum and sigmoid colon. This localized form of ulcerative colitis is characterized by continuous inflammation, mucosal edema, and ulcerations in the lining of these segments. Patients typically experience symptoms like rectal bleeding, urgency, frequent bowel movements, tenesmus, and lower abdominal pain. The disease follows a relapsing-remitting course, with periods of active inflammation and remission. Diagnosis is confirmed via colonoscopy with biopsies. Treatment focuses on inducing and maintaining remission, primarily using topical or oral aminosalicylates. Corticosteroids manage active flares, with immunomodulators or biologics for refractory cases. Ongoing management is crucial to prevent complications and improve quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months without treatment; days to weeks with effective treatment initiation.
Duration of Illness (Lifetime)
Lifelong, characterized by periods of active disease and remission.
Cost of Treatment (Initial)
Several hundred to a few thousand USD/EUR for initial diagnosis (e.g., colonoscopy, biopsies, lab tests) and medication.
Cost of Treatment (Lifetime)
Tens of thousands to hundreds of thousands USD/EUR, depending on disease severity, medication choice (especially biologics), and management of complications.
Mortality Rate
Very low; direct mortality from localized rectosigmoiditis is exceptionally rare with appropriate management.
Risk of Secondary Damages
Moderate to high for long-term complications like anemia or psychological distress (anxiety, depression); lower for severe physical complications like perforation or strictures specific to rectosigmoiditis; increased but manageable long-term risk of colorectal cancer.
Probability of Full Recovery
Very low; while remission (symptom-free with mucosal healing) is often achievable and maintained, the disease is chronic and generally not considered curable.
Underlying Disease Risk
Low to moderate for extra-intestinal manifestations (e.g., joint pain, skin lesions, eye inflammation) which can appear concurrently or develop over time; no specific underlying diseases are known to directly cause rectosigmoiditis.